Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dopamine agonists in Parkinson's disease.

D B Calne, K Burton, J Beckman

    The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
    |February 1, 1984
    PubMed
    Summary

    Dopamine agonists advance basal ganglia understanding by identifying dopamine receptor classes and non-impulse-driven effects. They offer clinical benefits for Parkinson's disease patients experiencing dyskinesia.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Guidelines for a sustainable return to work with long COVID.

    Occupational medicine (Oxford, England)·2025
    Same author

    Sustaining work ability amongst female professional workers with long COVID.

    Occupational medicine (Oxford, England)·2024
    Same author

    Advice to remain active with arm pain reduces disability.

    Occupational medicine (Oxford, England)·2023
    Same author

    What workers can tell us about post-COVID workability.

    Occupational medicine (Oxford, England)·2022
    Same author

    Primary cutaneous anaplastic large-cell lymphoma with marked spontaneous regression of organ manifestation after SARS-CoV-2 vaccination.

    The British journal of dermatology·2021
    Same author

    The Development and Content of the Vocational Advice Intervention and Training Package for the Study of Work and Pain (SWAP) Trial (ISRCTN 52269669).

    Journal of occupational rehabilitation·2018

    Area of Science:

    • Neuroscience
    • Pharmacology

    Background:

    • Dopamine agonists have significantly advanced the understanding of basal ganglia function.
    • They have aided in classifying dopamine receptor subtypes.
    • They revealed dopaminergic effects independent of neuronal impulse traffic, resembling endocrine signaling.

    Purpose of the Study:

    • To explore the role and mechanisms of dopamine agonists in basal ganglia.
    • To assess the clinical utility of dopamine agonists in Parkinson's disease.
    • To investigate potential future applications and improvements in pharmacotherapy.

    Main Methods:

    • Review of existing research on dopamine agonists and basal ganglia.
    • Analysis of clinical observations in Parkinson's disease patients.
    • Exploration of animal models for dopaminomimetic activity.

    Related Experiment Videos

    Main Results:

    • Dopamine agonists facilitated dopamine receptor classification.
    • Demonstrated dopaminergic effects independent of impulse traffic.
    • Showed clinical benefits in patients with dyskinesia and wearing-off reactions.

    Conclusions:

    • Dopamine agonists offer insights into basal ganglia function and Parkinson's disease treatment.
    • Potential for earlier, combined low-dose therapy with levodopa warrants further investigation.
    • Future agonists may feature prolonged effects and improved efficacy/toxicity profiles based on animal model correlations.